NLRP1 and Miyoshi myopathy: The role of NLRP1 in the pathogenesis of MM is supported by reported genetic association7 and constitutive activation of NLRP1 inflammasome leading to persistently increased production of downstream mediators (Caspase-1 and IL-1β) in malignant melanoma tissue12.